Bradycardia	bradycardia	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
hydrochloride	hydrochloride	O	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
chronic	chronic	O	O	O	O
schizophrenic	schizophrenic	O	DISEASE	OTHERS	I
patient	patient	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
anticholinergic	anticholinergic	O	O	O	O
drug	drug	O	O	O	O
,	,	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
hydrochloride	hydrochloride	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
developed	developed	O	O	O	O
,	,	O	O	O	O
paradoxically	paradoxically	O	O	O	O
,	,	O	O	O	O
sinus	sinus	O	DISEASE	OTHERS	I
bradycardia	bradycardia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
reaction	reaction	O	O	O	O
was	was	O	O	O	O
specific	specific	O	O	O	O
to	to	O	O	O	O
trihexyphenidyl	trihexyphenidyl	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
not	not	O	O	O	O
to	to	O	O	O	O
other	other	O	O	O	O
anticholinergic	anticholinergic	O	O	O	O
drugs	drugs	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
antidyskinetic	antidyskinetic	O	O	O	O
drug	drug	O	O	O	O
is	is	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
psychiatric	psychiatric	O	DISEASE	OTHERS	I
practice	practice	O	O	O	O
and	and	O	O	O	O
physicians	physicians	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
side	side	O	O	O	O
effect	effect	O	O	O	O
.	.	O	O	O	O

